Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
09/2000
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000054593A1 Iodine preparation compositon
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use
09/21/2000WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911053A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
09/21/2000DE19910697A1 Natural medicament useful for treating inflammation, rheumatism or skin disease, obtained from Aloe genus plants, honey and ethanol
09/21/2000DE19901502C1 Anticellulitiszusammensetzung und ihre Verwendung Anticellulitiszusammensetzung and their use
09/21/2000CA2747376A1 Use of lipoxin compounds for inhibiting of tnf-(alpha) initiated neutrophil response
09/21/2000CA2675416A1 Lipoxin compounds and their use
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3
09/21/2000CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000CA2367340A1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof
09/21/2000CA2367213A1 Novel antiangiogenic peptides
09/21/2000CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000CA2366174A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000CA2366130A1 Human cancer associated gene sequences and polypeptides
09/21/2000CA2365767A1 Angiogenesis inhibition
09/21/2000CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000CA2364739A1 Regulators of intracellular phosphorylation
09/21/2000CA2364635A1 47 human secreted proteins
09/21/2000CA2364629A1 Human lung cancer associated gene sequences and polypeptides
09/21/2000CA2364590A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000CA2364549A1 50 human secreted proteins
09/21/2000CA2363022A1 49 human secreted proteins
09/21/2000CA2361939A1 Modified amino acid amides, pharmaceutical compositions containing these compounds and processes for preparing them
09/21/2000CA2361819A1 Amide derivatives
09/21/2000CA2361770A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000CA2361503A1 Corticosteroid formulation
09/21/2000CA2361277A1 49 human secreted proteins
09/20/2000EP1036187A1 Process for the preparation of immunomodulatory polysaccharides from aloe
09/20/2000EP1036089A1 Wound healing compositions
09/20/2000EP1036087A1 Secreted proteins and polynucleotides encoding them
09/20/2000EP1036062A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
09/20/2000EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
09/20/2000EP1035864A2 Methods and compositions for the treatment of psoriasis
09/20/2000EP1035831A1 Use of carboxylic acid to stabilize or improve epidermal synthesized ceramide
09/20/2000EP1035828A2 Topical compositions for regulating the oily/shiny appearance of skin
09/20/2000EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
09/20/2000EP0734376B1 Vitamin d amine and amide derivatives
09/20/2000CN1267284A Carbostyril derivs. for inhibiting skin erythema and/or skin pigmentation
09/20/2000CN1267222A Polymeric compositions
09/20/2000CN1266694A Exterior-applied medicine for treating toxic sore
09/20/2000CN1266692A Chinese medicine for treating ephelis
09/20/2000CN1266691A Medicine for treating burn and scald
09/20/2000CN1266690A Powdered Chinese medicine for treating skin wound
09/20/2000CN1266681A Carbocisteine composition for promoting healing of wound and burn
09/20/2000CN1266679A Nanoemulsion based on ethoxylated fatly ether or ethoxylated fatty ester, and use thereof
09/20/2000CN1056608C Pseudodipeptide product having imidazole group and applications
09/20/2000CN1056534C Chinese medicine liquid for eliminating acne and skin care
09/20/2000CN1056531C Chinese medicine composition for treating skin disease
09/20/2000CN1056528C Silk ointment for promoting union of wound surface
09/20/2000CN1056524C Plaster for treating burn and scald and its preparation method
09/20/2000CN1056518C Plaster for treatment of surgical diseases, e. g. cellulitis, tumor etc.
09/20/2000CN1056515C 'Zizhi' medical cream
09/20/2000CN1056511C Process for preparing composition for beauty or pharmaceutical, especially dermotoses and antiallergy by using cucurbin, and use
09/19/2000US6121375 Gels formed by the interaction of poly(aldehyde) with various substances
09/19/2000US6121319 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
09/19/2000US6121317 Gibberellins (including gibberellins A3 and A7) used in ulcer or wound healing
09/19/2000US6121312 Cyclic ether vitamin D3 compounds and uses thereof
09/19/2000US6121300 In a topical cosmetic as skin elasticity improver or wrinkle reducer; compounds such as 3-(2-(3-phenyl-5-isoxazolyl)-2-oxoethyl)-thiazolium; adminsistering to treat cataracts, protein aging and diabetes
09/19/2000US6121297 Cyanoguanidines as cell proliferation inhibitors
09/19/2000US6121279 Phosphodiesterase inhibitor for treating respiratory system disorders
09/19/2000US6121274 Phosphodiesterase inhibitor for treatment of respiratory system disorders
09/19/2000US6121272 Bidentate metalloprotease inhibitors
09/19/2000US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease
09/19/2000US6121257 Sulfamate containing macrocyclic immunomodulators
09/19/2000US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith
09/19/2000US6121243 Prophylaxis of skin against ageing, against inflammation and for protection from photoreaction and oxidative influences
09/19/2000US6120785 Antimycotic ectoparasiticidal product-external use
09/19/2000US6120765 Purified peptide
09/19/2000US6120756 Topical anionic salicylate for disorders of the skin
09/19/2000CA2106768C Bradykinin type peptides
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053604A1 Carbamoyl tetrahydropyridine derivatives
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053232A1 Matriptase, a serine protease and its applications
09/14/2000WO2000053193A1 Pharmaceutical composition containing nitrate source and an acidifying agent for treating skin ischaemia
09/14/2000WO2000053185A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000037422A3 Ion channel modulating agents
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO1999063999A8 H1-histamine receptor antagonists
09/14/2000DE19911039A1 Abgewandelte Aminosäureamide, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Modified amino acid amides, pharmaceutical compositions containing them and methods for their preparation
09/14/2000CA2367130A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
1 ... 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 ... 1065